Hanan S. Anbar

Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells

Rawan M. Sbenati, Seyed–Omar Zaraei, Mohammed I. El–Gamal et al. · European Journal of Medicinal Chemistry · 2020 · 32 citations · Full text

Novel Conformationally-restricted Analogues, Hepatocellular Carcinoma, Medicine +7

Synthesis, biological evaluation, and docking studies of new raloxifene sulfonate or sulfamate derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase

Mohammed I. El–Gamal, Saif Ullah, Seyed–Omar Zaraei et al. · European Journal of Medicinal Chemistry · 2019 · 29 citations · Full text

Medicinal Chemistry, Pharmaceutical Science, Biochemistry +12

Design and synthesis of new quinoline derivatives as selective C-RAF kinase inhibitors with potent anticancer activity

Seyed–Omar Zaraei, Nour N. Alach, Hanan S. Anbar et al. · European Journal of Medicinal Chemistry · 2022 · 29 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Medicine +8

Synthesis, biological evaluation, and docking studies of new pyrazole-based thiourea and sulfonamide derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase

Saif Ullah, Mohammed I. El–Gamal, Sumera Zaib et al. · Bioorganic Chemistry · 2020 · 27 citations

Biochemistry, New Pyrazole-based Thiourea, Medicine +9

Discovery of first-in-class imidazothiazole-based potent and selective ErbB4 (HER4) kinase inhibitors

Seyed–Omar Zaraei, Rawan M. Sbenati, Nour N. Alach et al. · European Journal of Medicinal Chemistry · 2021 · 27 citations · Full text

Medicinal Chemistry, Drug Target, Biochemistry +12